MetaCap

Abivax SA Statistics

NASDAQ: ABVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

73.20-7.45 (-9.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Abivax SA by the numbers

Abivax SA has a market capitalization of $6.41 billion based on 87.54M shares outstanding. With trailing EPS of $-6.08, Abivax SA is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.7% below its 50-day average and 34.5% below its 200-day average.

Average daily trading volume is 1.35M shares, or about $98.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABVX valuation vs. peer median

ABVX compared with the median of 8 peer companies
MetricABVXPeer medianDifference
Market cap$6.41B$6.11B+5%
Avg. volume1.35M1.06M+27%

Peer median across 8 companies: MIRM, AXSM, SUPN, CORT, ARWR, CYTK, LGND, GRFS.

Valuation

Price and trading

Previous close
80.65
Open
79.01
Day range
62.97 – 79.74
52-week range
62.70 – 148.83
52-week change
-38.55%
Beta
—
Volume
14.85M

Dividends and events

Annual dividend
None
Next earnings date
Dec 21, 2026

Additional statistics

Market Cap
6.41B
Forward Pe
-19.09
Eps
-6.08
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
148.83
Week52 Low
62.70
Avg Volume
1.35M
Shares Outstanding
87.54M
Ma50
91.16
Ma200
111.78
Earnings Date
Dec 21, 2026
Pct From52w High
-50.82%
Pct From52w Low
16.75%

Related